Publication Information

{'id': 'https://openalex.org/W2026794782', 'doi': 'https://doi.org/10.1080/15569520903046934', 'title': 'Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma', 'display_name': 'Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma', 'publication_year': 2009, 'publication_date': '2009-01-01', 'ids': {'openalex': 'https://openalex.org/W2026794782', 'doi': 'https://doi.org/10.1080/15569520903046934', 'mag': '2026794782', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19548772'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/15569520903046934', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S52317855', 'display_name': 'Cutaneous and Ocular Toxicology', 'issn_l': '1556-9527', 'issn': ['1556-9527', '1556-9535'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5004588913', 'display_name': 'Zübeyde Nur Özkurt', 'orcid': 'https://orcid.org/0000-0001-9834-6058'}, 'institutions': [{'id': 'https://openalex.org/I95634034', 'display_name': 'Gazi University', 'ror': 'https://ror.org/054xkpr46', 'country_code': 'TR', 'type': 'education', 'lineage': ['https://openalex.org/I95634034']}], 'countries': ['TR'], 'is_corresponding': False, 'raw_author_name': 'Zübeyde Nur Özkurt', 'raw_affiliation_strings': ['Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.'], 'affiliations': [{'raw_affiliation_string': 'Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.', 'institution_ids': ['https://openalex.org/I95634034']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062649996', 'display_name': 'Gülsan Türköz Sucak', 'orcid': 'https://orcid.org/0000-0002-7707-0029'}, 'institutions': [{'id': 'https://openalex.org/I95634034', 'display_name': 'Gazi University', 'ror': 'https://ror.org/054xkpr46', 'country_code': 'TR', 'type': 'education', 'lineage': ['https://openalex.org/I95634034']}], 'countries': ['TR'], 'is_corresponding': False, 'raw_author_name': 'Gülsan Türköz Sucak', 'raw_affiliation_strings': ['Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.'], 'affiliations': [{'raw_affiliation_string': 'Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.', 'institution_ids': ['https://openalex.org/I95634034']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002144314', 'display_name': 'Şahika Zeynep Akı', 'orcid': 'https://orcid.org/0000-0002-3068-5085'}, 'institutions': [{'id': 'https://openalex.org/I95634034', 'display_name': 'Gazi University', 'ror': 'https://ror.org/054xkpr46', 'country_code': 'TR', 'type': 'education', 'lineage': ['https://openalex.org/I95634034']}], 'countries': ['TR'], 'is_corresponding': False, 'raw_author_name': 'Şahika Zeynep Akı', 'raw_affiliation_strings': ['Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.'], 'affiliations': [{'raw_affiliation_string': 'Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.', 'institution_ids': ['https://openalex.org/I95634034']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034997188', 'display_name': 'Münci Yağcı', 'orcid': 'https://orcid.org/0000-0002-0458-2920'}, 'institutions': [{'id': 'https://openalex.org/I95634034', 'display_name': 'Gazi University', 'ror': 'https://ror.org/054xkpr46', 'country_code': 'TR', 'type': 'education', 'lineage': ['https://openalex.org/I95634034']}], 'countries': ['TR'], 'is_corresponding': False, 'raw_author_name': 'Münci Yağcı', 'raw_affiliation_strings': ['Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.'], 'affiliations': [{'raw_affiliation_string': 'Hematology Department, Gazi University Faculty of Medicine, Ankara, Turkey.', 'institution_ids': ['https://openalex.org/I95634034']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5037975885', 'display_name': 'Özlem Erdem', 'orcid': 'https://orcid.org/0000-0002-5981-4856'}, 'institutions': [{'id': 'https://openalex.org/I95634034', 'display_name': 'Gazi University', 'ror': 'https://ror.org/054xkpr46', 'country_code': 'TR', 'type': 'education', 'lineage': ['https://openalex.org/I95634034']}], 'countries': ['TR'], 'is_corresponding': False, 'raw_author_name': 'Özlem Erdem', 'raw_affiliation_strings': ['Pathology Department, Gazi University Faculty of Medicine, Ankara, Turkey.'], 'affiliations': [{'raw_affiliation_string': 'Pathology Department, Gazi University Faculty of Medicine, Ankara, Turkey.', 'institution_ids': ['https://openalex.org/I95634034']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.437268, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 64, 'max': 71}, 'biblio': {'volume': '28', 'issue': '3', 'first_page': '141', 'last_page': '143'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10952', 'display_name': 'PI3K/AKT/mTOR signaling in cancer', 'score': 0.9957, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/autologous-stem-cell-transplantation', 'display_name': 'Autologous stem-cell transplantation', 'score': 0.521642}], 'concepts': [{'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.9760958}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.87742126}, {'id': 'https://openalex.org/C2778570526', 'wikidata': 'https://www.wikidata.org/wiki/Q653197', 'display_name': 'Rash', 'level': 2, 'score': 0.82531106}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7832835}, {'id': 'https://openalex.org/C2778367456', 'wikidata': 'https://www.wikidata.org/wiki/Q7251235', 'display_name': 'Proteasome inhibitor', 'level': 3, 'score': 0.7029108}, {'id': 'https://openalex.org/C2779609412', 'wikidata': 'https://www.wikidata.org/wiki/Q203174', 'display_name': 'Thalidomide', 'level': 3, 'score': 0.6645224}, {'id': 'https://openalex.org/C2779050716', 'wikidata': 'https://www.wikidata.org/wiki/Q4826373', 'display_name': 'Autologous stem-cell transplantation', 'level': 3, 'score': 0.521642}, {'id': 'https://openalex.org/C2775934546', 'wikidata': 'https://www.wikidata.org/wiki/Q179991', 'display_name': 'Biopsy', 'level': 2, 'score': 0.42229757}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.37256026}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.35581446}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3213845}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D003875', 'descriptor_name': 'Drug Eruptions', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': True}, {'descriptor_ui': 'D005076', 'descriptor_name': 'Exanthema', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D001706', 'descriptor_name': 'Biopsy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003875', 'descriptor_name': 'Drug Eruptions', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D003875', 'descriptor_name': 'Drug Eruptions', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D003875', 'descriptor_name': 'Drug Eruptions', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D003875', 'descriptor_name': 'Drug Eruptions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005076', 'descriptor_name': 'Exanthema', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D005076', 'descriptor_name': 'Exanthema', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D005076', 'descriptor_name': 'Exanthema', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D005076', 'descriptor_name': 'Exanthema', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/15569520903046934', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S52317855', 'display_name': 'Cutaneous and Ocular Toxicology', 'issn_l': '1556-9527', 'issn': ['1556-9527', '1556-9535'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19548772', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4281831295', 'https://openalex.org/W3146265467', 'https://openalex.org/W3032571198', 'https://openalex.org/W3029266790', 'https://openalex.org/W3028919400', 'https://openalex.org/W2105502495', 'https://openalex.org/W2092753516', 'https://openalex.org/W2053506257', 'https://openalex.org/W1973074169', 'https://openalex.org/W1732928399'], 'abstract_inverted_index': {'Bortezomib': [0], 'is': [1, 8], 'a': [2, 49], 'potent,': [3], 'selective': [4], 'proteasome': [5], 'inhibitor.': [6], 'It': [7], 'usually': [9], 'well': [10, 18], 'tolerated,': [11], 'and': [12, 61], 'bortezomib-induced': [13], 'skin': [14], 'lesions': [15], 'are': [16], 'less': [17], 'known.': [19], 'A': [20, 57], '59-year-old': [21], 'man': [22], 'with': [23], 'multiple': [24], 'myeloma': [25, 74], 'underwent': [26], 'autologous': [27], 'hematopoetic': [28], 'stem': [29], 'cell': [30], 'transplantation': [31], '(AHSCT).': [32], 'Administration': [33], 'of': [34, 55, 73, 80, 90, 100], 'bortezomib': [35], 'was': [36, 75], 'started': [37], 'after': [38, 77], 'AHSCT': [39], 'as': [40], 'his': [41], 'disease': [42], 'progressed': [43], 'despite': [44], 'thalidomide': [45], 'maintenance.': [46], 'He': [47], 'developed': [48], 'rash': [50, 66], 'afer': [51], 'the': [52, 91], 'third': [53], 'cycle': [54], 'bortezomib.': [56, 81], 'biopsy': [58], 'showed': [59], 'superficial': [60], 'deep': [62], 'perivascular': [63], 'dermatitis.': [64], 'The': [65, 82], 'resolved': [67], 'within': [68], '4': [69], 'days;': [70], 'complete': [71, 98], 'response': [72], 'obtained': [76], '8': [78], 'cycles': [79], 'benign': [83], 'clinical': [84], 'course': [85], 'did': [86], 'not': [87], 'require': [88], 'interruption': [89], 'treatment,': [92], 'which': [93], 'in': [94, 97], 'turn': [95], 'resulted': [96], 'remission': [99], 'myeloma.': [101]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2026794782', 'counts_by_year': [{'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-11T13:14:47.076043', 'created_date': '2016-06-24'}